Features - Boardroom

Filter

Current filters:

Boardroom

Popular Filters

1 to 25 of 129 results

Lupin appoints Theresa Stevens as Chief Corporate Development Officer

Lupin appoints Theresa Stevens as Chief Corporate Development Officer

23-04-2014

Pharma major Lupin has announced the appointment of Theresa Stevens as Chief Corporate Development Officer…

BoardroomLupinPharmaceuticalUSA

Novartis appoints Jeff George as Division Head, Alcon and Richard Francis as Division Head, Sandoz

Novartis appoints Jeff George as Division Head, Alcon and Richard Francis as Division Head, Sandoz

22-04-2014

Swiss drug major Novartis has announced the appointment of Jeff George as Division Head of Alcon and…

AlconBoardroomNorthern EuropeNovartisPharmaceuticalSandoz

e-Therapeutics announces appointment of Steve Medlicott as Finance Director

e-Therapeutics announces appointment of Steve Medlicott as Finance Director

22-04-2014

UK-based drug discovery and development company e-Therapeutics has announced the appointment of Steve…

BoardroomManagementPharmaceutical

Adcock Ingram appoints CEO

Adcock Ingram appoints CEO

22-04-2014

South African drugmaker Adcock Ingram has announced the appointment of Kevin Wakeford (pictured) as Chief…

Adcock IngramBoardroomPharmaceuticalSouth Africa

Jacques Servier, founder and president of Lab Servier, dies aged 92

17-04-2014

French independent drugmaker Laboratories Servier announced that its founder and president, Jacques Servier,…

BoardroomManagementPharmaceuticalServier

Astellas US promotes Jeffrey Bloss to SVP of medical affairs for the Americas

Astellas US promotes Jeffrey Bloss to SVP of medical affairs for the Americas

16-04-2014

The US subsidiary of Japanese drug major Astellas Pharma announced that Jeffrey Bloss has been promoted…

Astellas PharmaBoardroomManagementPharmaceuticalUSA

Interview: AstraZeneca’s oncology expert Susan Galbraith on the company’s exciting pipeline

Interview: AstraZeneca’s oncology expert Susan Galbraith on the company’s exciting pipeline

11-04-2014

The full year report from Anglo-Swedish drug major AstraZeneca (LSE: AZN) in February was full of optimism.…

AstraZenecaInterviewsIressaOncologyPharmaceuticalUK

EGA Biosimilars: Prescribers must be encouraged to use biosimilars

EGA Biosimilars: Prescribers must be encouraged to use biosimilars

07-04-2014

Uptake of biosimilars in Europe has increased as a result of member states’ policies, according to…

BiosimilarsEuropeFilgrastimInterviewsMarkets & MarketingRegulationSandoz

EGA Biosimilars: European monitoring and global business opportunities

EGA Biosimilars: European monitoring and global business opportunities

07-04-2014

The spotlight was on the European uptake of biosimilars at the European Generic medicines Association’s…

BiosimilarsEuropeGlobalInterviewsMarkets & Marketing

New Haven Pharmaceuticals appoints Larry Dillaha as Executive Vice President Operations

New Haven Pharmaceuticals appoints Larry Dillaha as Executive Vice President Operations

02-04-2014

New Haven Pharmaceuticals, a privately held specialty pharmaceuticals company, today announced the appointment…

BoardroomNew Haven PharmaceuticalsPharmaceuticalUSA

Paul Sekhri joins Sanofi as Senior Vice President

Paul Sekhri joins Sanofi as Senior Vice President

01-04-2014

Paul Sekhri has joined French drug major Sanofi as Senior Vice President, Integrated Care effective…

BiotechnologyBoardroomPharmaceuticalSanofiUSA

Inovio Pharmaceuticals appoints EJ Brandreth as vice president of quality

Inovio Pharmaceuticals appoints EJ Brandreth as vice president of quality

01-04-2014

USA-based Inovio Pharmaceuticals (NYSE MKT: INO) has announced the appointment of EJ Brandreth as Vice…

BoardroomInovio PharmaceuticalsPharmaceuticalUSA

Executive Q&A: Epigenomics’ chief executive Dr Thomas Taapken

Executive Q&A: Epigenomics’ chief executive Dr Thomas Taapken

01-04-2014

The Pharma Letter interviewed chief executive Dr Thomas Taapken about Epigenomics’ lead product, increasing…

BiotechnologyEpi proColonEpigenomicsGermanyInterviewsOncology

Par Pharmaceutical appoints Terrance Coughlin as chief operating officer

Par Pharmaceutical appoints Terrance Coughlin as chief operating officer

01-04-2014

Par Pharmaceutical Companies (NYSE: PRX) has announced the appointment of Terrance Coughlin as chief…

BoardroomPar PharmaceuticalPar PharmaceuticalsPharmaceuticalUSA

Sanofi appoints Dr Anne Beal as chief patient officer

Sanofi appoints Dr Anne Beal as chief patient officer

31-03-2014

French drug major Sanofi has announced the appointment of Anne Beal to the newly created position of…

BiotechnologyBoardroomFrancePharmaceuticalSanofiUSA

aTyr Pharma appoints David Weiner as Chief Medical Officer

aTyr Pharma appoints David Weiner as Chief Medical Officer

31-03-2014

aTyr Pharma, a rare disease biotherapeutics enterprise, has announced the appointment of David Weiner…

aTyrBiotechnologyBoardroomUSA

Adaptimmune announces appointment of James Noble as Chief Executive Officer

Adaptimmune announces appointment of James Noble as Chief Executive Officer

26-03-2014

Adaptimmune, a biotech company focused on the use of engineered T cells to treat cancer, has announced…

AdaptimmuneBiotechnologyBoardroomImmunocoreUK

Merck promotes internal top managers to head Merck Millipore and Consumer Health Divisions

Merck promotes internal top managers to head Merck Millipore and Consumer Health Divisions

26-03-2014

German pharma and chemical major Merck KGaA has announced the promotion of three distinguished internal…

AllergopharmaBiotechnologyBoardroomGermanyMerck KGaAPharmaceutical

Angle appointments new Scientific Adviser

Angle appointments new Scientific Adviser

26-03-2014

Angle (AIM:AGL), the specialist medtech company, has appointed Clive Stanway as a Scientific Adviser…

AngleBiotechnologyBoardroomCancer Research TechnologyOncologyUK

Novira names Christian Schade as chief executive officer

Novira names Christian Schade as chief executive officer

21-03-2014

Novira Therapeutics has announced the appointment of Christian Schade as chief executive officer, effective…

BoardroomPharmaceuticalUSA

Interview: Arnaud Grunwald of Model N on taking a holistic approach to revenue management

Interview: Arnaud Grunwald of Model N on taking a holistic approach to revenue management

20-03-2014

As health care budgets are squeezed worldwide and access issues continue to make the headlines, the price…

GlobalInterviewsPharmaceuticalPricing

Takeda appoints Giles Platford as Head of Emerging Markets

Takeda appoints Giles Platford as Head of Emerging Markets

19-03-2014

Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502) has announced the appointment of Giles…

BoardroomNorthern EuropePharmaceuticalTakeda Pharma GmbH

NeRRe Therapeutics announces appointment of Ian Nicholson as Chief Business Officer

NeRRe Therapeutics announces appointment of Ian Nicholson as Chief Business Officer

19-03-2014

UK-based company NeRRe Therapeutics, which is focused on the development of neurokinin (NK) receptor…

BoardroomNeRReTherapeuticsPharmaceuticalUK

1 to 25 of 129 results

Back to top